Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2009

01.03.2009 | Original Article

The Relationship Between Updated Sydney System Score and LDL Cholesterol Levels in Patients Infected with Helicobacter pylori

verfasst von: Metin Kucukazman, Bunyamin Yavuz, Muhammed Sacikara, Zeliha Asilturk, Naim Ata, Derun Taner Ertugrul, Ahmet Arif Yalcin, Ezgi Coskun Yenigun, Guler Kizilca, Heyecan Okten, Kadir Okhan Akin, Yasar Nazligul

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Objectives Helicobacter pylori (H. pylori) chronically infects the human stomach and may cause extra-gastrointestinal diseases. The role of H. pylori in the pathogenesis of atherosclerosis and its effect on lipids remains controversial. The aim of this study was to examine lipid levels in patients with and without H. pylori infection. Methods A total of 244 consecutive patients who underwent esophagogastroduodenoscopy were included in this study. Patients receiving statin and fibrate therapy and diabetic patients were excluded. Biopsies from each individual were taken and analyzed for H. pylori detection using ultrastructural methods. Patients were divided into two groups: H. pylori (+) (group 1) and H. pylori (−) (group 2). Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride levels were measured in all subjects. Results A total of 163 patients were included in group 1 and 81 patients were included in group 2. Frequency of H. pylori was 67% in the study population. Total cholesterol (204 ± 39 mg/dl versus 189 ± 42 mg/dl, respectively; P = 0.007) and LDL-C (128 ± 30 mg/dl versus 116 ± 32 mg/dl, respectively; P = 0.003) were significantly higher in group 1 than in group 2. Updated Sydney classification score showed a positive correlation with LDL-C (r = 0.333, P < 0.001) and TC (r = 0.288, P < 0.001) levels. Conclusion Increased levels of TC and LDL-C were found in patients infected with H. pylori, and updated Sydney System score showed a positive correlation with LDL-C and TC levels. These findings may explain why H. pylori infection is associated with increased risk of atherosclerosis.
Literatur
1.
Zurück zum Zitat Blaser MJ (1992) Helicobacter pylori: its role in disease. Clin Infect Dis 15:386–393PubMed Blaser MJ (1992) Helicobacter pylori: its role in disease. Clin Infect Dis 15:386–393PubMed
2.
Zurück zum Zitat Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 10:1161–1181CrossRef Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 10:1161–1181CrossRef
4.
Zurück zum Zitat Scragg RK, Fraser A, Metcalf PA (1996) Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce. J Epidemiol Community Health 50:578–579PubMedCrossRef Scragg RK, Fraser A, Metcalf PA (1996) Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce. J Epidemiol Community Health 50:578–579PubMedCrossRef
5.
Zurück zum Zitat Niemala S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, Kesaniemi YA (1996) Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 75:573–575. doi:10.1136/hrt.75.6.573 CrossRef Niemala S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, Kesaniemi YA (1996) Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 75:573–575. doi:10.​1136/​hrt.​75.​6.​573 CrossRef
6.
Zurück zum Zitat Hoffmeister A, Rothenbacher D, Bode G et al (2001) Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or Cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 21:427–432PubMed Hoffmeister A, Rothenbacher D, Bode G et al (2001) Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or Cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 21:427–432PubMed
7.
8.
9.
Zurück zum Zitat Zhang L, Gail MH, Wang YQ, Brown LM, Pan KF, Ma JL, Amagase H, You WC, Moslehi R (2006) A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr 84(4):912–919PubMed Zhang L, Gail MH, Wang YQ, Brown LM, Pan KF, Ma JL, Amagase H, You WC, Moslehi R (2006) A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr 84(4):912–919PubMed
13.
Zurück zum Zitat Gallin JL, Kaye D, O’Leary WM (1969) Serum lipid in infection. N Engl J Med 281:1081–1086PubMed Gallin JL, Kaye D, O’Leary WM (1969) Serum lipid in infection. N Engl J Med 281:1081–1086PubMed
14.
Zurück zum Zitat März W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR (2004) Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 110(19):3068–3074. doi:10.1161/01.CIR.0000146898.06923.80 PubMedCrossRef März W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR (2004) Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 110(19):3068–3074. doi:10.​1161/​01.​CIR.​0000146898.​06923.​80 PubMedCrossRef
Metadaten
Titel
The Relationship Between Updated Sydney System Score and LDL Cholesterol Levels in Patients Infected with Helicobacter pylori
verfasst von
Metin Kucukazman
Bunyamin Yavuz
Muhammed Sacikara
Zeliha Asilturk
Naim Ata
Derun Taner Ertugrul
Ahmet Arif Yalcin
Ezgi Coskun Yenigun
Guler Kizilca
Heyecan Okten
Kadir Okhan Akin
Yasar Nazligul
Publikationsdatum
01.03.2009
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2009
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0391-y

Weitere Artikel der Ausgabe 3/2009

Digestive Diseases and Sciences 3/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.